Evidence map›Paper›PMID 39565412›Full record

ArticleVirchows Archiv : an international journal of pathology2025

Conventional (bone-type) giant cell tumor of the larynx: the first case with proven H3-3A: c.103G >T (p.Gly35Trp) mutation.

Jan Laco, Hana Vosmikova, Jana Satankova, Jana Dedkova, Jan Mejzlik, Viktor Chrobok, Abbas Agaimy

Erratum issuedAbstract readCase Reports
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Jan LacoThe Fingerland Department of Pathology, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic. lacoj@lfhk.cuni.cz.ORCID http://orcid.org/0000-0002-9602-7501
Hana VosmikovaThe Fingerland Department of Pathology, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic.
Jana SatankovaDepartment of Otorhinolaryngology and Head and Neck Surgery, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
Jana DedkovaDepartment of Radiology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
Jan MejzlikDepartment of Otorhinolaryngology and Head and Neck Surgery, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
Viktor ChrobokDepartment of Otorhinolaryngology and Head and Neck Surgery, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
Abbas AgaimyInstitute of Pathology, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Erlangen, Germany.

Funding

Ministerstvo Školství, Mládeže a Tělovýchovy BBMRI-CZ LM2023033Ministerstvo Školství, Mládeže a Tělovýchovy Cooperatio ProgramMinisterstvo Školství, Mládeže a Tělovýchovy EF16_013/0001674Ministerstvo Školství, Mládeže a Tělovýchovy research area DIAGMinisterstvo Školství, Mládeže a Tělovýchovy SURG
6 · The paper itself

Abstract

This report documents the first case of a conventional (bone-type) giant cell tumor of the larynx, in which the diagnosis was confirmed by molecular genetic analysis. A 50-year-old non-smoking man experienced progressive hoarseness lasting for 3 months. Imaging showed a 40-mm tumor arising from the right thyroid cartilage. The total laryngectomy was performed. Grossly, the tumor was solid and whitish, with areas of hemorrhage. Microscopically, the tumor consisted of a biphasic population with mononuclear cells with round to oval nuclei, small nucleoli, and pale eosinophilic cytoplasm admixed with evenly distributed dispersed osteoclast-like giant cells. Immunohistochemically, the neoplastic mononuclear cells expressed diffusely vimentin and p63 and focally SATB2. Admixed mononuclear histiocytes coexpressed CD68 and CD163, while the osteoclast-like giant cells showed only CD68 expression. Most importantly, all mononuclear tumor cells showed strong nuclear expression of anti-histone H3.3 G34W antibody. Subsequent next-generation sequencing confirmed the missense mutation of gene H3-3A: c.103G>T (p.Gly35Trp).

Indexed as

Biomarkers, TumorGiant Cell TumorsHistonesLaryngeal NeoplasmsMutation, MissenseHumansImmunohistochemistryMaleMiddle AgedBiomarkers, TumorH3-3A protein, humanHistonesGiant cell tumorHistoneLarynxMolecular genotyping

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.